Results

Total Results: 2,463 records

Showing results for "testing".

101. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
     May 20, 2013 - Our decision to exclude breath testing was confirmed with the Key Informants. … WMC testing resulted in changes in management in 84% of patients. … as surrogates for motility testing or to exclude alarm conditions. … The Use of Colonic Testing to Guide Treatment in the Introduction chapter now states, “If testing confirms … “established” standards of upper and lower gut motility testing.

102. Advancing Measurement of Patient-Centered Communication in Cancer Care | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cancer-communication/research
     March 28, 2013 - independent SEG, and members had expertise in clinical cancer communication, survey design, cognitive testing … During pre-testing, the items functioned well overall. … The cancer patients who participated in the testing were generally able to understand the questions, … Additional steps are needed to finalize the items including additional cognitive testing, conducting

103. Lung Cancer Screening: A Clinician's Checklist (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-checklist.pdf
     March 01, 2016 - Discussed potential harms of lung cancer screening, including: » False-positive results » Followup testing … if an abnormality is found (and the possible complications of invasive testing) » Overdiagnosis … » Total radiation exposure (screening and diagnostic testing, cumulative) Discussed other issues: … b Symptomatic patients may need followup and diagnostic testing, but not screening. … This could lead to treatment of people who do not really need treatment. » Screening and followup testing

104. Lung Cancer Screening: A Clinician's Checklist (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-checklist.pdf
     March 01, 2016 - Discussed potential harms of lung cancer screening, including: » False-positive results » Followup testing … if an abnormality is found (and the possible complications of invasive testing) » Overdiagnosis … » Total radiation exposure (screening and diagnostic testing, cumulative) Discussed other issues: … b Symptomatic patients may need followup and diagnostic testing, but not screening. … This could lead to treatment of people who do not really need treatment. » Screening and followup testing

105. Is Lung Cancer Screening Right for Me? A decision aid for people considering lung cancer screening with low-dose computed tomography. (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-decision-aid.pdf
     March 01, 2016 - If you have smoked for many years, you may want to think about screening (testing) for lung cancer with … What is the difference between screening and diagnostic testing? … Screening is a medical term for testing to find a disease before it causes any symptoms or problems. … Diagnostic testing is not the same as screening. … If the screening test is positive, additional testing may involve higher doses of radiation.

106. Is Lung Cancer Screening Right for Me? A decision aid for people considering lung cancer screening with low-dose computed tomography. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-decision-aid.pdf
     March 01, 2016 - If you have smoked for many years, you may want to think about screening (testing) for lung cancer with … What is the difference between screening and diagnostic testing? … Screening is a medical term for testing to find a disease before it causes any symptoms or problems. … Diagnostic testing is not the same as screening. … If the screening test is positive, additional testing may involve higher doses of radiation.

107. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - or layered-testing strategies)? … layered-testing strategies? … or layered-testing strategies)? … or layered-testing strategies? … multiple testing or layered-testing strategies?

108. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
     August 04, 2023 - Additionally, owing to the overlapping findings of the C.difficile testing chapter in MHS III, our … rapid response will also subsume the C.difficile surveillance and testing topics as it relates to active … surveillance, along with screening and testing in asymptomatic patients. … in 2017, there has been an acceleration in publications evaluating C.difficile testing and diagnostic … of surveillance cannot be evaluated • Testing stewardship interventions • No microbial organism

109. Kidney Tests | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/kidney-tests/

110. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Links between testing, test results, and patient outcomes are complex. … Example: HIV testing Direct effects: Emotional distress from the testing process, cognitive/emotional … For example, testing for HIV has both direct and indirect effects. … summary testing performance (e.g., sensitivity, specificity). … The table shown classifies the results of PET testing.

111. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Links between testing, test results, and patient outcomes are complex. … Example: HIV testing Direct effects: Emotional distress from the testing process, cognitive/emotional … For example, testing for HIV has both direct and indirect effects. … summary testing performance (e.g., sensitivity, specificity). … The table shown classifies the results of PET testing.

112. FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
     May 01, 2013 - We found two studies evaluating WMC as an add-on to other testing. … Consensus guidelines suggest that WMC testing is a replacement for current testing methods, however … The next series of questions asked about the incremental value of WMC testing in addition to other testing … testing. … We found two studies evaluating WMC as an add-on to other testing.

113. Antibiotics-Respiratory-Infection Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_executive.pdf
     January 01, 2016 - Rapid Streptococcus Antigen Testing. … C-Reactive Protein Testing. … The combination of communication training and CRP testing was not different from CRP testing alone … + Procalcitonin testing + Rapid strep testing + Combination of patient and provider education plus audit … training, communication training plus CRP testing).

114. What is the comparative effectiveness of genetic and other diagnostic tests to identify and treat intellectual and developmental disabilities caused by genetic mutations in post-natal to early childhood populations? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-genetic-and-other-diagnostic-tests-to-identify-and-treat-intellectual-and-developmental-disabilities-caused-by-genetic-mutations-in-post-natal-to-early-childhood-populations
     October 26, 2012 - tests: Oligo- or SNP-based Chromosomal Microarray (CMA) High-resolution G-banded karyotype FMR1 testing … Determining this would address uncertainty policymakers and clinicians feel regarding the utility of genetic testing … One Medicaid director stated, "We have seen a significant number of claims for genetic testing in children … Our average reimbursement is approximately $1750.00 for this microarray testing. … Organization Please tell us how you heard about the Effective Health Care Program Genetic Testing

115. Antiplatelet-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
     September 01, 2013 - Genetic testing for CYP2C19 ii. … Genetic testing for CYP2C19 followed by phenotypic testing for platelet reactivity iii. … Phenotypic testing for platelet reactivity iv. No testing b. … Use of phenotypic testing (but not genetic testing) as a monitoring test can be considered a variation … Combined Testing for CYP2C19 Variants and Phenotypic Testing To Guide Antiplatelet Treatment Of the

116. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     July 29, 2010 - commercially available PCA3 expression assays for prostate cancer screening tests vs. screening by PSA testing … related outcomes resulting from improved/earlier detection of prostate cancer that may result from testing … Organization Please tell us how you heard about the Effective Health Care Program PCA3 Testing … in the Diagnosis and Management of Prostate Cancer: Future Research Needs PCA3 Testing for the Diagnosis

117. Immunity After COVID-19 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/immunity-after-covid/protocol
     September 10, 2020 - Although testing for antibodies to SARS-CoV-2 is becoming more common, how these tests should be utilized … What are the unintended consequences of antibody testing after SARS-CoV-2 infection? Table 1. … Include: KQ 1,4: Adults with viral RT-PCR confirmed SARS-CoV-2 infection who underwent serologic testing … KQ 2-3: Adults with viral RT-PCR confirmed SARS-CoV-2 infection who underwent serologic testing using … Early in the pandemic, PCR testing was strictly done on symptomatic patients to conserve resources in

118. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
     January 01, 2009 - Premature dissemination of testing technologies can lead to erroneous diagnoses and preventable delays … The ultimate question in decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size requirements can … be substantial.45 Trials of testing need a well-defined protocol that links testing, results, and downstream … All of these practical problems are challenging but not insurmountable, and trials of testing can be

119. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
     January 01, 2009 - Premature dissemination of testing technologies can lead to erroneous diagnoses and preventable delays … The ultimate question in decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size requirements can … be substantial.45 Trials of testing need a well-defined protocol that links testing, results, and downstream … All of these practical problems are challenging but not insurmountable, and trials of testing can be

120. Diagnosis of Celiac Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
     July 01, 2016 - Testing for the presence of HLA-DQ2 or HLA-DQ8 has excellent sensitivity and negative predictive value … For children younger than 2 years, the ACG guidelines recommend initial testing with tTG IgA, DGP IgA … a Sensitivity and specificity values are for point-of-care testing. b Sensitivity and specificity values … a Sensitivity and specificity values are for point-of-care testing. b Sensitivity and specificity values … Testing algorithms �� All algorithms studied used tTG tests.